UPDATE: White House Synthetic Bio Commission Urges Enhanced Oversight | GenomeWeb

This article has been updated with comments from the vice chair of the commission and a bioethicist.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A White House-appointed commission today recommended that federal agencies should oversee some areas of synthetic biology, such as regulation, product licensing, and funding, in order to protect the public from potential risks while not shackling promising research efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Replication studies that don't quite reflect the original findings underscore the need to better share data, the Wall Street Journal reports.

About two-thirds of proposals to work with select agents are denied — though most proposals that come in don't meet the definition of a restricted experiment, according to an analysis by the Centers for Disease Control and Prevention.

Researchers examine plant and human DNA found on the Shroud of Turin.

In PNAS this week: Plasmodium knowlesi population structure, 'pre-adaptations' in algal ancestors of land plants, and more.

Sponsored by

This webinar will focus on a range of research and clinical applications enabled by improvements in mate pair technology for whole genome sequencing.